An Open-label, Randomized, Four-way Crossover Study in Healthy Male Subjects to Assess the Relative Bioavailability of 4 Different Fostamatinib Tablets3.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Fostamatinib (Primary)
- Indications B cell lymphoma; Rheumatoid arthritis; Solid tumours; Systemic lupus erythematosus; T cell lymphoma
- Focus Pharmacokinetics
- 07 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2010 Actual initiation date added to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 20 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.